Integration of autosomal dominant AD patient CSF proteomics with brain tissue pathology identified SMOC1 as being abnormally elevated in the CSF nearly 30 years before the onset of cognitive symptoms, marking it as the earliest known biomarker of AD [200, 201]. Here, SMOC1 is linked to Alzheimer disease.